Paper376702
T cell helper defect in patients with chronic lymphocytic leukemia.
Chiorazzi N and 5 others. J Immunol, 1979. Cited by 198 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. T cell helper defect in patients with chronic lymphocytic leukemia. Papers, record 376702. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/376702
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Leukemia, Lymphoid | Major topic |
| T-Lymphocytes | Major topic |
| B-Lymphocytes | |
| Binding Sites, Antibody | |
| Classification | |
| Hemolytic Plaque Technique | |
| Humans | |
| Immunoglobulin Fc Fragments | |
| Immunoglobulin M | |
| Lymphocyte Activation | |
| Rosette Formation |
Source PubMed
Cited by50
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 198 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34,174,988 | Can Immunocompetence Be Restored in Chronic Lymphocytic Leukemia? | Hematol Oncol Clin North Am | 2021 | https://conductscience.org/library/papers/34174988 | PubMed |
| 33,631,756 | Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic. | Acta Haematol | 2021 | https://conductscience.org/library/papers/33631756 | PubMed |
| 33,466,674 | Hematopoietic versus Solid Cancers and T Cell Dysfunction: Looking for Similarities and Distinctions. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33466674 | PubMed |
| 33,375,215 | Molecular Remission Using Low-Dose Immunotherapy with Minimal Toxicities for Poor Prognosis IGHV- Unmutated Chronic Lymphocytic Leukemia. | Cells | 2020 | https://conductscience.org/library/papers/33375215 | PubMed |
| 30,148,696 | Is ibrutinib associated with disseminated cryptococcosis with CNS involvement? | Cancer Biol Ther | 2019 | https://conductscience.org/library/papers/30148696 | PubMed |
| 28,972,595 | Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD-L1 pathway. | Leukemia | 2018 | https://conductscience.org/library/papers/28972595 | PubMed |
| 28,197,963 | A Concise Review of Autoimmune Cytopenias in Chronic Lymphocytic Leukemia. | Curr Hematol Malig Rep | 2017 | https://conductscience.org/library/papers/28197963 | PubMed |
| 27,597,852 | Challenges in the Role of Gammaglobulin Replacement Therapy and Vaccination Strategies for Hematological Malignancy. | Front Immunol | 2016 | https://conductscience.org/library/papers/27597852 | PubMed |
| 27,158,669 | Chronic lymphocytic leukemia cells diversify and differentiate in vivo via a nonclassical Th1-dependent, Bcl-6-deficient process. | JCI Insight | 2016 | https://conductscience.org/library/papers/27158669 | PubMed |
| 27,118,475 | GIFT4 fusokine converts leukemic B cells into immune helper cells. | J Transl Med | 2016 | https://conductscience.org/library/papers/27118475 | PubMed |
| 26,337,493 | Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib. | Blood | 2015 | https://conductscience.org/library/papers/26337493 | PubMed |
| 26,015,797 | Sepsis due to Erysipelothrix rhusiopathiae in a patient with chronic lymphocytic leukemia associated with bronchopneumonia due to Pseudomonas aeruginosa and Escherichia coli: A case report. | Can J Infect Dis Med Microbiol | 2015 | https://conductscience.org/library/papers/26015797 | PubMed |
| 25,931,291 | Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: Natural history, clinical correlates, and outcomes. | Cancer | 2015 | https://conductscience.org/library/papers/25931291 | PubMed |
| 24,624,026 | Genetic polymorphisms, chronic lymphocytic leukemia, and the future: are we there yet? | Rev Bras Hematol Hemoter | 2014 | https://conductscience.org/library/papers/24624026 | PubMed |
| 23,984,126 | Improvement of paraneoplastic limbic encephalitis after systemic treatment with rituximab in a patient with B-cell chronic lymphocytic leukemia. | Case Rep Hematol | 2013 | https://conductscience.org/library/papers/23984126 | PubMed |
| 22,713,648 | Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function. | Leukemia | 2013 | https://conductscience.org/library/papers/22713648 | PubMed |
| 22,234,621 | Treatment of older patients with chronic lymphocytic leukemia. | Curr Hematol Malig Rep | 2012 | https://conductscience.org/library/papers/22234621 | PubMed |
| 20,620,969 | Chronic lymphocytic leukaemia: a disease of activated monoclonal B cells. | Best Pract Res Clin Haematol | 2010 | https://conductscience.org/library/papers/20620969 | PubMed |
| 19,965,642 | Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway. | Blood | 2010 | https://conductscience.org/library/papers/19965642 | PubMed |
| 12,208,878 | Chronic lymphocytic leukemia B cells can undergo somatic hypermutation and intraclonal immunoglobulin V(H)DJ(H) gene diversification. | J Exp Med | 2002 | https://conductscience.org/library/papers/12208878 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/376702
GET https://conductscience.org/api/papers/v1/376702/cited_by?page=2